期刊
THERANOSTICS
卷 4, 期 6, 页码 614-628出版社
IVYSPRING INT PUBL
DOI: 10.7150/thno.8478
关键词
Nanoparticles; photodynamic therapy; Positron Imaging Tomography; Reactive Oxygen species
资金
- NIH [RO1 CA127369]
- RPCI Support Grant [P30CA16056]
In this report we demonstrate the outstanding advantages of multifunctional nanoplatforms for cancer-imaging and therapy. The non-toxic polyacrylamide (PAA) nanoparticles (size: 18-25 nm) formulation drastically changed the pharmacokinetic profile of the I-124-labeled chlorophyll-a derivative (formulated in 10% ethanol in PBS) with a remarkable enhancement in tumor uptake, and significantly reduced uptake in spleen and liver. Among the various nanoformulations investigated, the I-124-labeled photosensitizer (dose: 0.6142 MBq), and the cyanine dye-nanoparticles (CD-NP) conjugate (dose 0.3 mu mol/kg) in combination showed great potential for tumor imaging (PET/NIR fluorescence) in BALB/c mice bearing Colon26 tumors. Compared to free non-labeled photosensitizer, the corresponding PAA nanoformulation under similar treatment parameters showed a remarkable enhancement in long-term tumor cure by PDT (photodynamic therapy) and provides an opportunity to develop a single nanoplatform for tumor-imaging (PET/fluorescence) and phototherapy, a practical See and Treat approach.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据